Brief: Sorrento Unit Appoints Elizabeth Czerepak As CFO
April 28 (Reuters) - Sorrento Therapeutics Inc SRNE.O :
* SCILEX HOLDING COMPANY A MAJORITY-OWNED SUBSIDIARY OF
SORRENTO
THERAPEUTICS, INC., APPOINTS HIGHLY ACCOMPLISHED LIFE SCIENCE
EXECUTIVE, ELIZABETH CZEREPAK, AS EXECUTIVE VICE PRESIDENT,
CHIEF FINANCIAL OFFICER (CFO) AND CHIEF BUSINESS OFFICER (CBO)
Source text for Eikon: ID:nGNXmxGng
Further company coverage: SRNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20